Horizon to Acquire US Rights for VIMOVO from Pozen

By: Benzinga
POZEN (NASDAQ: POZN ) today announced that AstraZeneca AB (NYSE: AZN ) and Horizon Pharma USA, Inc. (NASDAQ: HZNP ) have entered into an agreement for Horizon to acquire the U.S.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.